| Primary |
| Diarrhoea |
44.1% |
| Crohn's Disease |
8.8% |
| Colitis |
5.9% |
| Anxiety |
4.9% |
| Hypertension |
3.9% |
| Irritable Bowel Syndrome |
3.9% |
| Back Pain |
2.9% |
| Neuropathy Peripheral |
2.9% |
| Blood Cholesterol Abnormal |
2.0% |
| Breast Cancer Metastatic |
2.0% |
| Cardiac Disorder |
2.0% |
| Convulsion |
2.0% |
| Depression |
2.0% |
| Diabetes Mellitus |
2.0% |
| Muscle Disorder |
2.0% |
| Non-hodgkin's Lymphoma |
2.0% |
| Product Used For Unknown Indication |
2.0% |
| Sjogren's Syndrome |
2.0% |
| Urinary Tract Disorder |
2.0% |
| Abdominal Pain |
1.0% |
|
| Drug Ineffective |
26.1% |
| Diarrhoea |
8.7% |
| Drug Screen False Positive |
6.5% |
| Malaise |
6.5% |
| Abdominal Pain |
4.3% |
| Expired Drug Administered |
4.3% |
| Loss Of Consciousness |
4.3% |
| Muscle Spasms |
4.3% |
| Pharyngeal Oedema |
4.3% |
| Rash |
4.3% |
| Swelling Face |
4.3% |
| Weight Increased |
4.3% |
| Abdominal Pain Upper |
2.2% |
| Bedridden |
2.2% |
| Blood Alkaline Phosphatase Increased |
2.2% |
| Completed Suicide |
2.2% |
| Constipation |
2.2% |
| Dehydration |
2.2% |
| Drug Abuse |
2.2% |
| Drug Hypersensitivity |
2.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
17.0% |
| Crohn's Disease |
13.8% |
| Hypertension |
8.2% |
| Product Used For Unknown Indication |
6.8% |
| Diarrhoea |
6.7% |
| Diabetes Mellitus |
5.5% |
| Chest Pain |
5.2% |
| Cardiac Disorder |
4.2% |
| Convulsion |
4.2% |
| Muscle Spasms |
4.0% |
| Blood Cholesterol Increased |
3.9% |
| Depression |
2.9% |
| Neuropathy Peripheral |
2.7% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Insomnia |
2.5% |
| Migraine |
2.4% |
| Diuretic Therapy |
2.1% |
| Colitis |
1.9% |
| Lung Disorder |
1.7% |
| Lung Adenocarcinoma |
1.6% |
|
| Emphysema |
14.1% |
| Diarrhoea |
11.5% |
| Amnesia |
7.7% |
| Vestibular Disorder |
7.7% |
| Weight Increased |
7.7% |
| Chronic Obstructive Pulmonary Disease |
5.1% |
| Vomiting |
5.1% |
| Bedridden |
3.8% |
| Dehydration |
3.8% |
| Expired Drug Administered |
3.8% |
| Nausea |
3.8% |
| Rash |
3.8% |
| Weight Decreased |
3.8% |
| Blood Potassium Decreased |
2.6% |
| Constipation |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Electrolyte Imbalance |
2.6% |
| Erythema |
2.6% |
| Off Label Use |
2.6% |
| Product Quality Issue |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.6% |
| Drug Use For Unknown Indication |
16.6% |
| Crohn's Disease |
11.4% |
| Diarrhoea |
7.4% |
| Pain |
5.1% |
| Nausea |
4.2% |
| Hypertension |
3.9% |
| Hiv Infection |
3.3% |
| Depression |
2.7% |
| Anxiety |
2.5% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Multiple Myeloma |
2.2% |
| Breast Cancer |
2.0% |
| Prophylaxis |
1.9% |
| Non-small Cell Lung Cancer |
1.6% |
| Osteoporosis |
1.5% |
| Diabetes Mellitus |
1.3% |
| Colitis Ulcerative |
1.2% |
| Colorectal Cancer Metastatic |
1.2% |
| Vitamin Supplementation |
1.1% |
|
| Vomiting |
18.3% |
| Weight Decreased |
11.4% |
| Diarrhoea |
7.5% |
| Urinary Tract Infection |
5.6% |
| Death |
4.6% |
| Renal Failure Acute |
4.4% |
| Pneumonia |
4.2% |
| Weight Increased |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Renal Failure |
3.7% |
| Thrombocytopenia |
3.7% |
| Nausea |
3.6% |
| Rash |
3.5% |
| Dehydration |
3.3% |
| Pyrexia |
3.3% |
| Injection Site Pain |
3.2% |
| Vision Blurred |
3.2% |
| Myocardial Infarction |
2.8% |
| Pain |
2.8% |
| Drug Ineffective |
2.5% |
|
| Interacting |
| Dyspepsia |
66.7% |
| Smoking Cessation Therapy |
33.3% |
|
| Intestinal Obstruction |
50.0% |
| Pancreatic Carcinoma |
50.0% |
|
